Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16943)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2019 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li TY, Yang Y, Zhou G, Tu ZK. Immune suppression in chronic hepatitis B infection associated liver disease: A review. World J Gastroenterol 2019; 25(27): 3527-3537 [PMID: 31367154 DOI: 10.3748/wjg.v25.i27.3527] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i27/3527.htm |
| Number | Citing Articles |
| 1 |
Mehmet Koroglu, Muhammed Ali Ayvaz, Suat Baran Bakan, Abdullatif Sirin, Umit Akyuz. Can quantitative surface antigen levels and systemic immune-inflammation index be predictive as a new indicator for the initiation of treatment in chronic hepatitis b?. European Journal of Gastroenterology & Hepatology 2024; 36(4): 489 doi: 10.1097/MEG.0000000000002737
|
| 2 |
Wen Hou, Xiaoli Wu. Diverse Functions of γδ T Cells in the Progression of Hepatitis B Virus and Hepatitis C Virus Infection. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.619872
|
| 3 |
Chanseop Park, Seon Yeong Ji, Hyun Hwangbo, Seung-yeon Shin, Min Yeong Kim, Kiuk Lee, Da Hye Kim, Bo-Ram Cho, Hyesook Lee, Yung Hyun Choi, Hyun Ju You. Enhancement of Immune Functions by Limosilactobacillus reuteri KBL346: In Vitro and In Vivo Studies. International Journal of Molecular Sciences 2023; 25(1): 141 doi: 10.3390/ijms25010141
|
| 4 |
Yiya Zhang, Ju Zou, Ruochan Chen. An M0 macrophage-related prognostic model for hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09872-y
|
| 5 |
Yu Liu, Hongying Guo, Wei Yuan, Ying Zou, Zhiping Qian, Xue Mei, Liujuan Ji, Jiefei Wang, Yuyi Zhang. HIV-Negative Case of Talaromyces marneffei Pulmonary Infection with Liver Cirrhosis in China: A Case Report and Literature Review. Infection and Drug Resistance 2024; : 1333 doi: 10.2147/IDR.S451880
|
| 6 |
Laiba Masood, Nayyer Islam, Muhammad Irfan, Ameer Fawad Zahoor, Haroon Khalid Syed, Muhammad Shahid Shah, Muhammad Ajmal Shah, Muhammad Ali Syed, Sana Hanif. Infectious Diseases Drug Delivery Systems. 2023; : 331 doi: 10.1007/978-3-031-20521-7_15
|
| 7 |
Hui Xiang, Xiaojun Tang, Meng Xiao, Lin Gan, Kun Chu, Shan Li, Yu Tian, Xun Lei. Study on Status and Willingness towards Hepatitis B Vaccination among Migrant Workers in Chongqing, China: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 2019; 16(20): 4046 doi: 10.3390/ijerph16204046
|
| 8 |
Syed Messum Ali Kazmi, Rabia Iftikhar. Biopsychosocial Determinants of Quality of Life in Patients with Hepatitis B and C. Pakistan Journal of Health Sciences 2023; : 85 doi: 10.54393/pjhs.v4i10.1077
|
| 9 |
Béatrice Laupèze, Ventzislav Vassilev, Selim Badur. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments. Expert Review of Gastroenterology & Hepatology 2023; 17(11): 1135 doi: 10.1080/17474124.2023.2268503
|
| 10 |
Yang Si, Jiwei Zhang, Shisan Bao, Steven G. Wise, Yuli Wang, Yanfang Zhang, Yuhong Tang. IL-32 and IL-34 in hepatocellular carcinoma. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1051113
|
| 11 |
Muttiah Barathan, Behnaz Riazalhosseini, Thevambiga Iyadorai, Kumutha Malar Vellasamy, Jamuna Vadivelu, Li-Yen Chang, Ahmad Khusairy Zulpa, Marie Larsson, Esaki M. Shankar, Rosmawati Mohamed. Comparative expression of pro-inflammatory and apoptotic biosignatures in chronic HBV-infected patients with and without liver cirrhosis. Microbial Pathogenesis 2021; 161: 105231 doi: 10.1016/j.micpath.2021.105231
|
| 12 |
Ali Shojaeian, Mohsen Nakhaie, Zahra Sobhi Amjad, Armin Khaghani Boroujeni, Somayeh Shokri, Shahab Mahmoudvand. Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2023.147
|
| 13 |
Liyuan Wang, Yuchen Fan. Current Advances of Innate and Adaptive Immunity in Acute-on-Chronic Hepatitis B Liver Failure. Infectious Diseases & Immunity 2022; 2(2): 113 doi: 10.1097/ID9.0000000000000051
|
| 14 |
Hong-Qin Xu, Chun-Guang Wang, Qiang Zhou, Yan-Hang Gao. Effects of alcohol consumption on viral hepatitis B and C. World Journal of Clinical Cases 2021; 9(33): 10052-10063 doi: 10.12998/wjcc.v9.i33.10052
|
| 15 |
Mina Rahmati, Mojtaba Zare Ebrahimabad, Alale Langari, Ali Najafi, Shohreh Taziki, Alireza Norouzi, Mehrdad Teimoorian, Milad Khorasani, Saeed Mohammadi. Rosuvastatin Intervention in Patients with Chronic Hepatitis B (CHB) Expands CD14+ CD16− Classical Monocytes via Aryl Hydrocarbon Receptor (AHR). Immuno 2024; 4(2): 159 doi: 10.3390/immuno4020011
|
| 16 |
Michel Bazinet, Mark Anderson, Victor Pântea, Gheorghe Placinta, Iurie Moscalu, Valentin Cebotarescu, Lilia Cojuhari, Pavlina Jimbei, Liviu Iarovoi, Valentina Smesnoi, Tatina Musteata, Alina Jucov, Ulf Dittmer, Jeff Gersch, Vera Holzmayer, Mary Kuhns, Gavin Cloherty, Andrew Vaillant. Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy. Hepatology Communications 2021; 5(11): 1873 doi: 10.1002/hep4.1767
|
| 17 |
Irina Volinsky. Mathematical Model of Hepatitis B Virus Treatment with Support of Immune System. Mathematics 2022; 10(15): 2821 doi: 10.3390/math10152821
|
| 18 |
Sheida Behzadi Sheikhrobat, Shahab Mahmoudvand, Salva Kazemipour-Khabbazi, Zahra Ramezannia, Hossein Bannazadeh Baghi, Somayeh Shokri. Understanding lactate in the development of Hepatitis B virus-related hepatocellular carcinoma. Infectious Agents and Cancer 2024; 19(1) doi: 10.1186/s13027-024-00593-4
|
| 19 |
Lixin Xiao, Kang Tang, Ting Fu, Xiaojie Yuan, Samuel Seery, Weilu Zhang, Zhaohua Ji, Zhen He, Yan Yang, Wenhua Zhang, Wenling Jia, Chunhui Liang, Haitao Tang, Fengmei Wang, Yancheng Ye, Lihua Chen, Zhongjun Shao. Cytokine profiles and virological markers highlight distinctive immune statuses, and effectivenesses and limitations of NAs across different courses of chronic HBV infection. Cytokine 2024; 173: 156442 doi: 10.1016/j.cyto.2023.156442
|
| 20 |
Н.А. Онищенко, А.О. Никольская, М.Ю. Шагидулин. Progressive dysfunction of the immune system as a factor preventing recoverable regeneration of the liver in chronic fibrosing diseases. Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» 2023; 67(3): 109 doi: 10.25557/0031-2991.2023.03.109-123
|
| 21 |
Kang Li, Ling Qin, Sanjie Jiang, Ang Li, Chi Zhang, Guihai Liu, Jianping Sun, Huanqing Sun, Yan Zhao, Ning Li, Yonghong Zhang. The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation. Clinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-00847-z
|
| 22 |
Xing Li, Jin-Long Li, Nan Jiang, Jie Chen, Zi-Ming Liang, Zhen-Lin Zhao, Yan-Fang Xing. Accumulation of LOX-1+ PMN-MDSCs in nasopharyngeal carcinoma survivors with chronic hepatitis B might permit immune tolerance to epstein–barr virus and relate to tumor recurrence. Aging 2021; 13(1): 437 doi: 10.18632/aging.202149
|
| 23 |
Xue-qin Lin, Jing-yi Rao, Yi-fei Xiang, Li-wei Zhang, Xiao-ling Cai, Yan-song Guo, Kai-yang Lin. Case Report: A Rare Syncope Case Caused by Abernethy II and a Review of the Literature. Frontiers in Cardiovascular Medicine 2022; 8 doi: 10.3389/fcvm.2021.784739
|
| 24 |
Xiao Wang, Keyan Wang, Cuipeng Qiu, Bofei Wang, Xiaojun Zhang, Yangcheng Ma, Liping Dai, Jian-Ying Zhang. Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC Patients. Biomedicines 2022; 10(1): 97 doi: 10.3390/biomedicines10010097
|
| 25 |
Murali Ganesan, Allison Eikenberry, Larisa Y Poluektova, Kusum K Kharbanda, Natalia A Osna. Role of alcohol in pathogenesis of hepatitis B virus infection. World Journal of Gastroenterology 2020; 26(9): 883-903 doi: 10.3748/wjg.v26.i9.883
|
| 26 |
Faisal Mahmood, Ruixian Xu, Maher Un Nisa Awan, Yuzhu Song, Qinqin Han, Xueshan Xia, Jia Wei, Jun Xu, Juan Peng, Jinyang Zhang. HBV Vaccines: Advances and Development. Vaccines 2023; 11(12): 1862 doi: 10.3390/vaccines11121862
|
| 27 |
Katsuyoshi Shimozawa, Laura Contreras-Ruiz, Sofia Sousa, Ruan Zhang, Urvashi Bhatia, Kerry C. Crisalli, Lisa L. Brennan, Laurence A. Turka, James F. Markmann, Eva C. Guinan. Ex vivo generation of regulatory T cells from liver transplant recipients using costimulation blockade. American Journal of Transplantation 2022; 22(2): 504 doi: 10.1111/ajt.16842
|
| 28 |
Zhanqing Zhang, Wei Lu, Dong Zeng, Dan Huang, Weijia Lin, Li Yan, Yanling Feng. Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection. Journal of Clinical Medicine 2021; 10(23): 5617 doi: 10.3390/jcm10235617
|
| 29 |
Jie Wu, Yu Yu, Yuzhu Dai, Yingjie Zhang, Jun Cheng, Dawei Cui. Research Progress on the Mechanism of Persistent Low-Level HBsAg Expression in the Serum of Patients with Chronic HBV Infection. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/1372705
|
| 30 |
Haimanti Bhattacharya, Debaprasad Parai, Subrat Kumar Sahoo, Aparjita Swain, Matrujyoti Pattnaik, Ira Mohapatra, Hariram Choudhary, Girish Chandra Dash, Nausaba Akhtar, Jaya Singh Kshatri, Debdutta Bhattacharya, Sanghamitra Pati. Hepatitis B virus infection among the tribal and particularly vulnerable tribal population from an eastern state of India: Findings from the serosurvey in seven tribal dominated districts, 2021–2022. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1039696
|
| 31 |
Chuanfang Luo, Shuhui Yu, Jinping Zhang, Xingrao Wu, Zhongyan Dou, Zheng Li, E. Yang, Lan Zhang. Hepatitis B or C viral infection and the risk of cervical cancer. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00466-8
|
| 32 |
Alexander Glover, Zhaoqin Zhang, Claire Shannon-Lowe. Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1161848
|
| 33 |
Cina Karimaghaei, Subahari Raviskanthan, Zane D. Foster, Peter W. Mortensen, Andrew G. Lee. Internuclear Ophthalmoplegia Due to Cryptococcal Meningitis. Journal of Neuro-Ophthalmology 2023; 43(4): e264 doi: 10.1097/WNO.0000000000001353
|
| 34 |
Jun Chen, Jinping Fu, Sha Zhao, Xiaoxi Zhang, Yuyang Chao, Qunxing Pan, Huawei Sun, Jingfeng Zhang, Bin Li, Tao Xue, Jingui Li, Chuanmin Liu. Free Radical and Viral Infection: A Review from the Perspective of Ferroptosis. Veterinary Sciences 2023; 10(7): 456 doi: 10.3390/vetsci10070456
|
| 35 |
Marina Manea, Dimitri Apostol, Ileana Constantinescu. The Connection between MiR-122 and Lymphocytes in Patients Receiving Treatment for Chronic Hepatitis B Virus Infection. Microorganisms 2023; 11(11): 2731 doi: 10.3390/microorganisms11112731
|
| 36 |
Peter D Block, Brianna Shinn, Jin Hyang Kim, Hie-Won Hann. Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes. Hepatic Oncology 2021; 8(1) doi: 10.2217/hep-2020-0028
|
| 37 |
Shenghong Sun, Ding Shi, Wei Wang. Risk of chronic liver disease and cirrhosis mortality among patients with digestive system cancers: a registry-based analysis. Clinical and Experimental Medicine 2023; 23(8): 5355 doi: 10.1007/s10238-023-01199-7
|
| 38 |
Simone Berger, Yanira Zeyn, Ernst Wagner, Matthias Bros. New insights for the development of efficient DNA vaccines. Microbial Biotechnology 2024; 17(11) doi: 10.1111/1751-7915.70053
|
| 39 |
Alaa Tajeldeen Habeeb Abdallah, Rami Elsiddig Abdelkhalig, Elwasila Hamid, Ayman Ahmed, Emmanuel Edwar Siddig. Recurrent abdominal wall mass in a hepatitis B‐positive male: An unusual case of lumbar mycetoma. Clinical Case Reports 2023; 11(12) doi: 10.1002/ccr3.8275
|
| 40 |
Qiuyun Yi, Jinxian Yang, Ying Wu, Ying Wang, Qiqi Cao, Wen Wen. Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1204524
|
| 41 |
Hua-Jun Zhao, Yi-Fei Hu, Qiu-Ju Han, Jian Zhang. Innate and adaptive immune escape mechanisms of hepatitis B virus. World Journal of Gastroenterology 2022; 28(9): 881-896 doi: 10.3748/wjg.v28.i9.881
|
| 42 |
Yating Zhan, Qiqi Tao, Zhichao Lang, Lifan Lin, Xinmiao Li, Suhui Yu, Zhengping Yu, Guangyao Zhou, Kaifeng Wu, Zhenxu Zhou, Zhixian Yu, Jianjian Zheng. Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and monitoring liver fibrosis in chronic hepatitis B patients. Journal of Medical Virology 2023; 95(10) doi: 10.1002/jmv.29157
|
| 43 |
Hye-Sung Jo, Johann Faizal Khan, Jae Hyun Han, Young-Dong Yu, Dong-Sik Kim. Efficacy and Safety of Hepatitis B Virus Vaccination Following Hepatitis B Immunoglobulin Withdrawal After Liver Transplantation. Transplantation Proceedings 2021; 53(10): 3016 doi: 10.1016/j.transproceed.2021.09.038
|
| 44 |
Shiyue Zhou, Zixuan Zhao, Hao Zhong, Zehao Ren, Yuye Li, Hong Wang, Yuling Qiu. The role of myeloid-derived suppressor cells in liver cancer. Discover Oncology 2023; 14(1) doi: 10.1007/s12672-023-00681-8
|
| 45 |
Jeremy M. Kelm, Hariprasad Aruri, Prasanth R. Nyalapatla, Navnath S. Gavande. Fused Pyrimidine-Based Drug Discovery. 2023; : 165 doi: 10.1016/B978-0-443-18616-5.00005-3
|
| 46 |
Bianqiao Cheng, Dandan Wu, Ming Zhang, Shiming Chen, Xunyuan Wu, Jingjing Zhong, Meimei Wu, Miaomiao Huo. High immunocompetence in chronic hepatitis patients with normal alanine transaminase levels and and negative hepatitis B e‐antigen for the progression of liver fibrosis. Immunity, Inflammation and Disease 2024; 12(1) doi: 10.1002/iid3.1134
|
| 47 |
Robério Amorim de Almeida Pondé, Guilherme de Sousa Pondé Amorim. Elimination of the hepatitis B virus: A goal, a challenge. Medicinal Research Reviews 2024; 44(5): 2015 doi: 10.1002/med.22030
|
| 48 |
Genju Wang, Fangping Yue, Ziyue Zhang, Yandan Wu, Ruixue Ji, Guanlun Zhou, Ying Ji, Chuanlai Shen. Comparison of HBV-specific T cell reactivity across the pregnant, postpartum and non-pregnant women with chronic HBV infection. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1461767
|
| 49 |
Huajun Zhao, Yating Yu, Yucan Wang, Lianhui Zhao, Ailu Yang, Yifei Hu, Zhaoyi Pan, Zixuan Wang, Jiarui Yang, Qiuju Han, Zhigang Tian, Jian Zhang. Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction. Cellular & Molecular Immunology 2022; 19(12): 1347 doi: 10.1038/s41423-022-00939-1
|
| 50 |
Fernando Martínez-Esquivias, Juan Manuel Guzmán-Flores, Alejandro Pérez-Larios, Napoleón González Silva, Julieta Saraí Becerra-Ruiz. A Review of the Antimicrobial Activity of Selenium Nanoparticles. Journal of Nanoscience and Nanotechnology 2021; 21(11): 5383 doi: 10.1166/jnn.2021.19471
|
| 51 |
Bushra Tahreem, Ghadir Ali, Haroon Ahmad, Asim Shahzad, Muhammad Khurram, Nabiha Naeem, Aquib Nazar, Muhammad Haris, Hassan ., Shahrukh .. Genotypes Variation and Molecular Epidemiology Of The Hbv Chronic Liver Infection In The Local Population Of Pakistan: An Overview Of The Recent Literature. Pakistan BioMedical Journal 2022; doi: 10.54393/pbmj.v5i4.372
|
| 52 |
Dong-Ling Wan, Li-Qi Sun. Timing of antiviral therapy in patients with hepatitis B virus related hepatocellular carcinoma undergoing hepatectomy. World Journal of Clinical Oncology 2024; 15(9): 1251-1255 doi: 10.5306/wjco.v15.i9.1251
|
| 53 |
Yi He, Yingzhi Zhou, Huimin Wang, Jingyang Yin, Yunan Chang, Peng Hu, Hong Ren, Hongmei Xu. Identifying potential biomarkers in hepatitis B virus infection and its response to the antiviral therapy by integrated bioinformatic analysis. Journal of Cellular and Molecular Medicine 2021; 25(14): 6558 doi: 10.1111/jcmm.16655
|
| 54 |
Ke Shi, Ping Li, Dongying Xue, Yao Liu, Qun Zhang, Ranchong Ping, Xianbo Wang. Neutrophil–lymphocyte ratio and the risk of hepatocellular carcinoma in patients with hepatitis B-caused cirrhosis. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e686 doi: 10.1097/MEG.0000000000002217
|
| 55 |
João Panão Costa, Armando de Carvalho, Artur Paiva, Olga Borges. Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression. Pharmaceuticals 2024; 17(7): 964 doi: 10.3390/ph17070964
|
| 56 |
Arshi Khanam, Joel V. Chua, Shyam Kottilil. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. International Journal of Molecular Sciences 2021; 22(11): 5497 doi: 10.3390/ijms22115497
|
| 57 |
Yahya Shadi, Bahram Heshmati, Jalal Poorolajal. Interaction between hepatitis B, hepatitis C and smoking in the development of hepatocellular carcinoma: a systematic review and meta-analysis. Journal of Public Health 2024; 46(1): 51 doi: 10.1093/pubmed/fdad214
|
| 58 |
Zebin Chen, Hong Jiang, Yuanqi Wang, Ruiming Liang, Lixia Xu, Jiaming Lai, Jingxian Shen, Jiali Li, Dongming Li, Shaoqiang Li, Kai Lei, Qian Zhou, Baogang Peng, Hong Peng, Sui Peng, Ming Kuang. Three‐day postoperative antibiotics reduces post‐hepatectomy infection rate in hepatitis B virus‐related hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2021; 36(9): 2531 doi: 10.1111/jgh.15528
|
| 59 |
Satoshi KUBOKI, Katsunori FURUKAWA, Tsukasa TAKAYASHIKI, Shigetsugu TAKANO, Masaru MIYAZAKI, Masayuki OHTSUKA. Clinical implication of ICG test in major hepatectomy for biliary tract cancer. Minerva Surgery 2021; 76(3) doi: 10.23736/S2724-5691.21.08580-1
|
| 60 |
Xia Li, Hong-Yan Wang, Fan Gao, Fan-Fan Guo, Xiao-Na Wang, Yi-Xia Pan, Gui-Qin Bai. Tenofovir alters the immune microenvironment of pregnant women with hepatitis B virus infection: Evidence from single-cell RNA sequencing. International Immunopharmacology 2023; 119: 110245 doi: 10.1016/j.intimp.2023.110245
|
| 61 |
Yan Xu, Xiaolei Zhou, Xuesong Wang, Yu Jin, Lin Zhou, Junsong Ye. Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis. Biomedicine & Pharmacotherapy 2024; 176: 116848 doi: 10.1016/j.biopha.2024.116848
|
| 62 |
Chieh-Lung Cheng, Wei-Quan Fang, Yu-Jen Lin, Chang-Tsu Yuan, Bor-Sheng Ko, Jih-Luh Tang, Hwei-Fang Tien. Hepatitis B surface antigen positivity is associated with progression of disease within 24 months in follicular lymphoma. Journal of Cancer Research and Clinical Oncology 2022; 148(5): 1211 doi: 10.1007/s00432-021-03719-y
|
| 63 |
Fatemeh Ebrahimi, Ali Modaresi Movahedi, Mohammad Sabbaghian, Vahdat Poortahmasebi. A State‐of‐the‐Art Review on the Recent Advances in Exosomes in Oncogenic Virus. Health Science Reports 2024; 7(11) doi: 10.1002/hsr2.70196
|
| 64 |
Jinglan Jin, Yuwei Liu, Xiaotong Xu, Zhongfeng Wang, Junqi Niu. The association between Fc gamma RIIb expression levels and chronic hepatitis B virus infection progression. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06918-7
|
| 65 |
Xingyue Zeng, Ayibaota Bahabayi, Bulidierxin Tuerhanbayi, Mohan Zheng, Tianci Liu, Lijuan Xu, Yan Long, Changsheng Xia, Songsong Lu, Ying Song, Chen Liu. The altered HLA‐DQ expression in peripheral blood T cells of chronic hepatitis B patients characterizes the function of T cells. Journal of Viral Hepatitis 2022; 29(5): 340 doi: 10.1111/jvh.13669
|
| 66 |
Ruo‐Ran Zhou, Ya‐Hui Song, Cheng‐Yu Xu, Ying‐Ying Zhang, Xiang‐Wei Wu, Lu Zhang, Xi‐Ni Luo, Han Zhao, Ming‐Ming Liu, Jun‐Chi Xu, Lin Wang, Zu‐Tao Chen, Qing‐Zhen Han. Altered counts and mitochondrial mass of peripheral blood leucocytes in patients with chronic hepatitis B virus infection. Journal of Cellular and Molecular Medicine 2024; 28(12) doi: 10.1111/jcmm.18440
|
| 67 |
Ying Zhang, Wei Guo, Zhumei Zhan, Ou Bai. Carcinogenic mechanisms of virus-associated lymphoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1361009
|
| 68 |
Jingying Qiu, Qingqing Zhou, Yinpeng Zhang, Mingyu Guan, Xin Li, Yueting Zou, Xuan Huang, Yali Zhao, Wang Chen, Xiaoke Gu. Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents. European Journal of Medicinal Chemistry 2020; 205: 112581 doi: 10.1016/j.ejmech.2020.112581
|
| 69 |
Guanrong Chen, Xin Hu, Yingchen Huang, Xiaonan Xiang, Sheng Pan, Ronggao Chen, Xiao Xu. Role of the immune system in liver transplantation and its implications for therapeutic interventions. MedComm 2023; 4(6) doi: 10.1002/mco2.444
|
| 70 |
Teng Wei, Bing-yu Zhou, Xin-Hong Wu, Xue-Ai Liu, Ming-Wei Huo, Xiang-Xiang Huang, Ling-Zhi Shi, Li-Li Shi, Qin-Ri Cao. Development of Polyvinyl Alcohol/Polyethylene Glycol Copolymer-based
Orodispersible Films Loaded with Entecavir: Formulation and In vitro
Characterization. Current Drug Delivery 2024; 21(10): 1362 doi: 10.2174/0115672018261294231024093926
|
| 71 |
Wenbiao Chen, Xujun Zhang, Kefan Bi, Hetong Zhou, Jia Xu, Yong Dai, Hongyan Diao. Comprehensive Study of Tumor Immune Microenvironment and Relevant Genes in Hepatocellular Carcinoma Identifies Potential Prognostic Significance. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.554165
|
| 72 |
Ting Song, Li Li, Bin Su, Lifeng Liu, Yan Liu, Xiaodong Yang, Qiuyue Zhang, Na Guo, Tong Zhang, Guizhen Sun, Hao Wu. NKG2C+ natural killer cell function improves the control of HBV replication in individuals with acute HIV infection coinfected with HBV. Medicine 2020; 99(18): e20073 doi: 10.1097/MD.0000000000020073
|
| 73 |
Weihua Cao, Minghui Li, Lu Zhang, Yao Lu, Shuling Wu, Ge Shen, Min Chang, Ruyu Liu, Yuanjiao Gao, Hongxiao Hao, Leiping Hu, Wei Yi, Calvin Q. Pan, Yao Xie, Udayan Apte. The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/2178143
|
| 74 |
Hai Cheng, Fenglan Sun, Yaoling Ouyang, Chengbin Li. Correlation analysis of IL‐37 gene polymorphisms and susceptibility to chronic HBV infection among Han people in Central China. International Journal of Immunogenetics 2023; 50(6): 299 doi: 10.1111/iji.12638
|
| 75 |
Sheila Makiala-Mandanda, Jessica L. Abbate, Elisabeth Pukuta-Simbu, Steve Ahuka-Mundeke, Jean-Jacques Muyembe-Tamfum, Eric M. Leroy, Pierre Becquart. Herpes Infections in Suspected Cases of Yellow Fever in the Democratic Republic of the Congo. Medicina 2021; 57(9): 871 doi: 10.3390/medicina57090871
|
| 76 |
Lili Zhou, Shaohuai Xia, Yaoyao Liu, Qiang Ji, Lifeng Li, Xuan Gao, Xiaodi Guo, Xin Yi, Feng Chen. A lipid metabolism–based prognostic risk model for HBV–related hepatocellular carcinoma. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01780-9
|
| 77 |
Xu Cao, Xiaobin Zao, Baiquan Xue, Hening Chen, Jiaxin Zhang, Shuo Li, Xiaobin Li, Shun Zhu, Rui Guo, Xiaoke Li, Yong’an Ye. The mechanism of TiaoGanYiPi formula for treating chronic hepatitis B by network pharmacology and molecular docking verification. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87812-9
|
| 78 |
Eric N. Y. Nyarko, Christian Obirikorang, W. K. B. A. Owiredu, Evans Asamoah Adu, Emmanuel Acheampong. Assessment of the performance of haematological and non-invasive fibrotic indices for the monitoring of chronic HBV infection: a pilot study in a Ghanaian population. BMC Research Notes 2023; 16(1) doi: 10.1186/s13104-023-06581-y
|
| 79 |
Avik Biswas, Sibnarayan Datta. Editorial: Origin and evolution of hepatitis viruses, volume II. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1241705
|
| 80 |
Efthymios P Tsounis, Athanasia Mouzaki, Christos Triantos. Nucleic acid vaccines: A taboo broken and prospect for a hepatitis B virus cure. World Journal of Gastroenterology 2021; 27(41): 7005-7013 doi: 10.3748/wjg.v27.i41.7005
|
| 81 |
Efthymios P Tsounis, Evanthia Tourkochristou, Athanasia Mouzaki, Christos Triantos. Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure. World Journal of Gastroenterology 2021; 27(21): 2727-2757 doi: 10.3748/wjg.v27.i21.2727
|
| 82 |
Poornima Ramburrun, Mershen Govender, Yahya E. Choonara. Nanomedicines for the Prevention and Treatment of Infectious Diseases. AAPS Advances in the Pharmaceutical Sciences Series 2023; 56: 349 doi: 10.1007/978-3-031-39020-3_12
|
| 83 |
Zhuo Li, Na Zhang, Zewen Dong, Xin Wang, Jian Zhou, Juan Gao, Yunyun Yang, Jing Li, Feng Guan, Yue Zhou, Zengqi Tan. Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01569-y
|
| 84 |
Lan Yang, Siyuan Tian, Xiaohong Zheng, Miao Zhang, Xinmin Zhou, Yulong Shang, Ying Han. N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment. Journal of Gastroenterology 2023; 58(8): 718 doi: 10.1007/s00535-023-02008-4
|
| 85 |
Markus Bo Schoenberg, Yongsheng Han, Xiaokang Li, Xinyu Li, Julian Nikolaus Bucher, Nikolaus Börner, Dominik Koch, Markus Otto Guba, Jens Werner, Alexandr V. Bazhin. Dynamics of Peripheral Blood Immune Cells during the Perioperative Period after Digestive System Resections: A Systematic Analysis of the Literature. Journal of Clinical Medicine 2023; 12(2): 718 doi: 10.3390/jcm12020718
|
| 86 |
TIANXING LIU, HONGYAN DIAO. A double-edged sword: The HBV-induced non-coding RNAs alterations in hepatocellular carcinoma. BIOCELL 2023; 47(1): 27 doi: 10.32604/biocell.2022.023568
|
| 87 |
Yini Pan, Zhenxin Wang, Zhichao Yan, Haofan Sun, Lingyi Zhang, Weibing Zhang. Novel Strategy for Screening Target Proteins by the Common Drugs─Sofosbuvir-Specific Profiling of HCV Patient Serum. Analytical Chemistry 2024; 96(23): 9535 doi: 10.1021/acs.analchem.4c00993
|
| 88 |
Ruyi Zhang, Huaie Liu, Jie Lin, Jie Ding, Jing You, Jiawei Geng. AhR may be involved in Th17 cell differentiation in chronic hepatitis B. Journal of Viral Hepatitis 2023; 30(12): 939 doi: 10.1111/jvh.13883
|
| 89 |
Yunpeng Wang, Haoyue Yang, Jiajin Hu, Yuecai Jiang, Wentao Ma, Shikong Gao, Dekun Chen. Preparation and application of fluorescent monoclonal antibodies recognizing goat CD4+CD25+ regulatory T cells. Applied Microbiology and Biotechnology 2024; 108(1) doi: 10.1007/s00253-024-13115-4
|
| 90 |
Ting Xiao, Jiali Bao, Jiao Tian, Rong Lin, Zihui Zhang, Yuxin Zhu, Yiming He, Dandi Gao, Ronghao Sun, Fubo Zhang, Yexin Cheng, Jiadelati Shaletanati, Honggang Zhou, Chunfeng Xie, Cheng Yang. Flavokawain A suppresses the vasculogenic mimicry of HCC by inhibiting CXCL12 mediated EMT. Phytomedicine 2023; 112: 154687 doi: 10.1016/j.phymed.2023.154687
|
| 91 |
Yujia Li, Shilin Li, Xiaoqiong Duan, Chunhui Yang, Min Xu, Limin Chen. Macrophage Phenotypes and Hepatitis B Virus Infection. Journal of Clinical and Translational Hepatology 2020; 8(4): 1 doi: 10.14218/JCTH.2020.00046
|
| 92 |
Yuchen Wan, Zhixue Wang, Ning Yang, Fenye Liu. Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.911961
|
| 93 |
Melissa Montoya-Guzmán, Carolina Posada-Álvarez, Laura Camila Lopera-Restrepo, Diana di Filippo-Villa, María-Cristina Navas. Infección por el virus de la hepatitis delta. Hepatología 2020; : 116 doi: 10.52784/27112330.120
|
| 94 |
Seth A. Domfeh, Patrick W. Narkwa, Osbourne Quaye, Kwadwo A. Kusi, Odalys Rivera, Martin M. Danaah, Baba A.N. Musah, Gordon A. Awandare, Kwesi B. Mensah, Mohamed Mutocheluh. Cryptolepine and Nibima inhibit hepatitis B virus replication. Scientific African 2021; 13: e00942 doi: 10.1016/j.sciaf.2021.e00942
|
| 95 |
Yanqiao Zhang, Haonan Jiang, Haimeng Yin, Xinyuan Zhao, Yali Zhang. Emerging Roles of B56 Phosphorylation and Binding Motif in PP2A-B56 Holoenzyme Biological Function. International Journal of Molecular Sciences 2024; 25(6): 3185 doi: 10.3390/ijms25063185
|
| 96 |
Yun Cai, Hailei Ji, Xin Zhou, Kai Zhao, Xiaoping Zhang, Liang Pan, Ruihua Shi. Interleukin-21 modulates balance between regulatory T cells and T-helper 17 cells in chronic hepatitis B virus infection. BMC Infectious Diseases 2023; 23(1) doi: 10.1186/s12879-023-08723-w
|